Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products. The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide. Read More
COLUMBUS, Ohio, April 23, 2026 (GLOBE NEWSWIRE) -- BrewDog USA by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), today unveiled its lineup of headliner products and bold innovation bets for spring and summer, signaling a renewed focus on flavor, disruption, and momentum across craft beer and emerging beverage categories in the U.S. With the strength of its core brands and the backing of Tilray Brands, BrewDog USA is accelerating an innovation-led growth strategy built around standout products designed to win with today’s modern drinker.
According to Dr. Sanjay Gupta, his long-running documentary series “Weed” has grown far beyond its original scope, evolving into an ongoing examination of cannabis, medicine, and patient experience.
According to Dr. Sanjay Gupta, his long-running documentary series “Weed” has grown far beyond its original scope, evolving into an ongoing examination of cannabis, medicine, and patient experience.
Tilray shares rally as Trump urges the DOJ to quickly reclassify cannabis as a Schedule III drug. Options pricing suggests TLRY stock could rip higher through mid-September.
NEW YORK and LEAMINGTON, Ontario, April 20, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today marked 4/20 by reinforcing its leadership in medical cannabis and its commitment to advancing patient care through a science-driven global platform.
Tilray Advances UK Healthcare Platform with Lyphe Acquisition, Positions BrewDog for Strong Growth, and Prepares for U.S. Rescheduling and Medical Cannabis Opportunity
A state-appointed advisory panel is urging North Carolina legislators to move toward legalizing cannabis under a controlled system that would permit adult sales. The group argues that regulation would improve public safety and generate significant revenue for the state.
A state-appointed advisory panel is urging North Carolina legislators to move toward legalizing cannabis under a controlled system that would permit adult sales. The group argues that regulation would improve public safety and generate significant revenue for the state.
Tilray Brands (NASDAQ:TLRY) has officially transitioned from a volatile cannabis producer to a diversified global consumer packaged goods (CPG) powerhouse, reporting record-breaking Q3 fiscal 2026 results. The company posted net revenue of $207 million, a figure driven by a stunning recovery in its beverage segment and explosive growth in
NEW YORK — Tilray Brands, Inc. (NASDAQ:TLRY) delivered a resounding message to the market this week, reporting a record-breaking $206.7 million in net revenue for its fiscal 2026 third quarter. The results, released on April 1, 2026, showcase a company successfully navigating a complex global landscape by pivoting toward
